Drug: NICODERM CQ Injury: Application site vesicles Quarter: 2016Q3
Total Records: 5 Number of Pages: 1
Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
---|---|---|---|---|---|---|---|---|
125401241 | NICODERM CQ | Application site vesicles | GLAXOSMITHKLINE | 55.00 YR | 0 | 20160708 | US | |
127245181 | NICODERM CQ | Application site vesicles | FDA-CTU | 43.00 YR | M | 97 KG | 20160908 | US |
127459921 | NICODERM CQ | Application site vesicles | GLAXOSMITHKLINE | 34.00 YR | F | 0 | 20160915 | US |
127461421 | NICODERM CQ | Application site vesicles | GLAXOSMITHKLINE | 0.00 | M | 0 | 20160915 | US |
127723351 | NICODERM CQ | Application site vesicles | GLAXOSMITHKLINE | 46.00 YR | F | 0 | 20160922 | US |
Total Records: 5 Number of Pages: 1